Status:
UNKNOWN
Cluster Analysis of the Risk of Metabolic Syndrome in Women for Reproductive Age
Lead Sponsor:
Taipei Medical University WanFang Hospital
Conditions:
Metabolic Cardiovascular Syndrome
Eligibility:
FEMALE
13-48 years
Brief Summary
The metabolic syndrome (MetS) is a cluster of clinical indices that signals increased risk for cardiovascular disease and Type 2 diabetes. Women with polycystic ovary syndrome (PCOS) were associated w...
Detailed Description
Definitions of the metabolic syndrome based on arbitrary cutoff points for several quantitative variables, where each variable is related linearly to cardiovascular risk. Even consensual definitions d...
Eligibility Criteria
Inclusion
- Women had been fulfilled with whole anthropometric measurements, clinic and biochemical survey about cardiovascular study.
Exclusion
- women who had been diagnosed with malignant tumor, Asherman's syndrome, Mullerian agenesis, and chromosomal anomalies;
- women who had had menarche less than 1 years before evaluation or who were older than 49;
- women who received hormones or drugs for major medical diseases within three months of blood sampling.
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2014
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT01826357
Start Date
March 1 2013
End Date
February 1 2014
Last Update
November 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
WanFang Medical Center at Taipei Medical University
Taipei, Taiwan, Taiwan, 116